Antineoplastic Drug Administration: Vesicant and Irritant Agents ...

extravasation of a vesicant agent. Disconnected IV tubing and disposed of it in an appropriate hazardous waste container. Attached a syringe to the IV cannula and attempted to aspirate residual vesicant. Removed the cannula or port needle. Notified the practitioner of possible extravasation. Determined if an antidote could be administered. ................
................